Home
NEWS
PRESS RELEASE
ENTERTAINMENT
ARTS & THEATRE
CELEBRITY
SHOWS
SOCIAL MEDIA
SPORTS
BUISNESS
CRYPTO
ECONOMY
FINANCE
MARKET
TECH
APPS
GADGET
SCIENCE
GAMING
LIFESTYLE
CULTURE
EDUCATION
FASHION
FOOD
HEALTH
MONEY
MUSIC
RELIGION
TRAVEL
BLOG
TOP LOCAL PROFESSIONALS
West Virginia Digital News
/
MARKET
/
Annovis Bio’s stock rockets 76% after reporting positive data in Parkinson’s disease trial
Annovis Bio’s stock rockets 76% after reporting positive data in Parkinson’s disease trial
The stock is on track for its best performance since May 21, 2021, when it gained 127%.
Source link
Previous Post
Germany's Deutsche Bahn a ‘national embarrassment’ amid Euro 2024
Next Post
Google’s greenhouse gas emissions climbed nearly 50 percent in five years due to AI